🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: molecular residual disease detection

Found 22 matching trials

Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)

N/A

The goal of this observational study or is to explore the correlation betwe...

Status

Recruiting

Location

Sun Yat-sen University Cancer Center

Start Date

2024-08-26

Trial ID

NCT06561178

Treatments Being Tested

molecular residual disease detection

ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy

N/A

The goal of this observational study is to explore whether ctDNA-MRD dynami...

Status

Not Yet Recruiting

Location

Department of Thoracic Surgery, Second Xiangya Hospital of Central South University, China

Start Date

2023-04

Trial ID

NCT05822284

Treatments Being Tested

NGS and ctDNA-MRD detection

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

N/A

This is a combined prospective and retrospective observational study aiming...

Status

Recruiting

Location

Department of Pharmacology, Yonsei University College of Medicine

Start Date

2024-08-21

Trial ID

NCT07035587

Treatments Being Tested

Serial Blood Sampling for Molecular Profiling One-Time Blood Sampling for Molecular Profiling

CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01

In cooperation with the molecular tumor board of the University Hospital Tü...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2023-10

Trial ID

NCT05871593

Treatments Being Tested

Molecular genetic diagnostic

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

N/A

Based on the unique patented MONOD and Methyl Titan methylation sequencing ...

Status

Recruiting

Location

Shanghai Pulmonary Hospital

Start Date

2023-10-25

Trial ID

NCT05965024

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

PHASE2

The purpose of this study is to investigate the use of ctDNA measurements t...

Status

Recruiting

Location

NYU Langone Health

Start Date

2026-04-13

Trial ID

NCT07504796

Treatments Being Tested

Nivolumab Relatlimab Ipilimumab Signatera genome MRD assay

Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer

PHASE2

The goal of this clinical study is to determine whether monitoring ctDNA an...

Status

Not Yet Recruiting

Location

Nagoya City University

Start Date

2026-01-10

Trial ID

NCT07292207

Treatments Being Tested

Abemaciclib 150 MG Oral Tablet

Biological Analysis of MABs in NHL in a Translational Prospective Observational Study Within Italian Clinical Practice

N/A

This a prospective, multicenter, observational pharmacological translationa...

Status

Not Yet Recruiting

Location

Ematologia - Fondazione del Piemonte per l'Oncologia - IRCCS

Start Date

2026-10

Trial ID

NCT07767799

Treatments Being Tested

WP1 - Task 1 - Liquid analyses WP1 - Task 2 - Immunological analyses WP1 - Task 3 - Tumor tissue analyses WP1 - Task 4 - Imaging analyses WP1 - Task 5 - Microbiome and metabolomics analyses WP2 - Task 1 - Liquid analyses WP2 - Task 2 -Immunological analyses WP2 - Task 3 - Tumor tissue analyses WP2 - Task 4 - Imaging analyses WP2 - Task 5 - Microbiome and metabolomics analyses WP3 - Task 1 - Liquid analyses WP3 - Task 2 - Immunological analyses WP3 - Task 3 - Tumor tissue analyses WP3 - Task 4 - Imaging analyses WP3 - Task 5 - Microbiome and metabolomics analyses

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

PHASE1

This is a phase 1 clinical trial to evaluate the safety, feasibility and im...

Status

Recruiting

Location

AdventHealth

Start Date

2025-03-20

Trial ID

NCT06529822

Treatments Being Tested

Synthetic long peptide personalized cancer vaccine Poly ICLC Signatera assay

Precision Medicine for Every Child With Cancer

N/A

To improve outcomes for childhood cancer patients through the implementatio...

Status

Recruiting

Location

Women's and Children's Hospital

Start Date

2022-12-16

Trial ID

NCT05504772

Treatments Being Tested

Whole Genome Sequencing RNA seq DNA Methylation Targeted Panel Sequencing High Throughput Sequencing (in vitro)Patient Derived Xenograft (PDX)(in vivo)Liquid Biopsy

Previous Next